Aquamin, a marine derived multi-mineral, attenuates toll-like receptor-mediated inflammatory responses in macrophages

Emmanouil Lioudakis1, Sakshi Hans1, Denise M O'Gorman2

  • 1Department of Pharmacology and Therapeutics, School of Medicine, Trinity College Dublin, Dublin, Ireland.

Frontiers in Immunology
|August 19, 2026
PubMed

Insights

Aquamin, a marine algae supplement, reduces inflammatory cytokine production by modulating Toll-like receptor (TLR) signaling pathways. This suggests Aquamin

Area of Science:

  • Immunology
  • Pharmacology
  • Marine Biotechnology

Background:

  • Toll-like receptors (TLRs) are key in innate immunity, recognizing pathogen- and damage-associated molecular patterns.
  • TLR activation triggers inflammatory cytokine release via MyD88- and TRIF-dependent pathways.
  • Aquamin, derived from marine algae, exhibits known anti-inflammatory effects.

Purpose of the Study:

  • To investigate Aquamin's impact on TLR-mediated inflammatory responses.
  • To elucidate the signaling pathways involved in Aquamin's anti-inflammatory action.

Main Methods:

  • Human peripheral blood mononuclear cells (hPBMCs) and murine bone marrow-derived macrophages (mBMDMs) were treated with Aquamin.
  • Cells were stimulated with lipopolysaccharide (LPS) or Poly(I:C) to activate TLRs.
  • Pro-inflammatory cytokine and chemokine production was measured.
  • Cytotoxicity was assessed.

Main Results:

  • Aquamin dose-dependently suppressed TNF-α and IL-6 production induced by LPS and Poly(I:C).
  • Aquamin did not exhibit cytotoxicity in tested cell types.
  • The anti-inflammatory effects align with modulation of TRIF-associated signaling downstream of TLR3 and TLR4.

Conclusions:

  • Aquamin effectively suppresses TLR-induced pro-inflammatory cytokine and chemokine production.
  • Aquamin's mechanism involves modulating TRIF-dependent TLR signaling.
  • Aquamin shows potential as a therapeutic agent for inflammatory diseases linked to TLR dysregulation.